Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Takeda and Amylin terminate obesity compound co-development agreement
Takeda and Amylin terminate obesity compound co-development agreement
Takeda and Amylin terminate obesity compound co-development agreement
Submitted by
admin
on December 29, 2012 - 10:38am
Source:
equities.com
News Tags:
Takeda
Amylin
obesity
weight loss
Headline:
Takeda and Amylin terminate obesity compound co-development agreement
Do Not Allow Advertisers to Use My Personal information
